Search research articles
Contact Us
Filters
Showing results (311-320 of 324) with videos related to
Page
of 33
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity
Claudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Nature Structural & Molecular Biology
|
January 8, 2020
A bipartite structural organization defines the SERINC family of HIV-1 restriction factors
Valerie E Pye, Annachiara Rosa, Cinzia Bertelli, et al.
Gene Therapy
|
May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival
Saqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Journal of Virology
|
July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants
Mathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Gene Therapy
|
July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicity
Saqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Xenotransplantation
|
September 2, 2014
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation
Mee Kum Kim, Hyuk Jin Choi, Ivo Kwon, et al.
Advances in Therapy
|
May 1, 2024
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 16, 2013
Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts
Linda Scobie, Vered Padler-Karavani, Stephanie Le Bas-Bernardet, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 21, 2026
Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Calcified Tissue International
|
August 4, 2022
Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study
Maria Luisa Brandi, Suzanne Jan de Beur, Karine Briot, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 324) with videos related to
Sort By:
Page
of 33
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity
Claudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Nature Structural & Molecular Biology
|
January 8, 2020
A bipartite structural organization defines the SERINC family of HIV-1 restriction factors
Valerie E Pye, Annachiara Rosa, Cinzia Bertelli, et al.
Gene Therapy
|
May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival
Saqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Journal of Virology
|
July 21, 2021
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants
Mathieu Ferrari, Leila Mekkaoui, F Tudor Ilca, et al.
Gene Therapy
|
July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicity
Saqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Xenotransplantation
|
September 2, 2014
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation
Mee Kum Kim, Hyuk Jin Choi, Ivo Kwon, et al.
Advances in Therapy
|
May 1, 2024
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 16, 2013
Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts
Linda Scobie, Vered Padler-Karavani, Stephanie Le Bas-Bernardet, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
May 21, 2026
Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-Trial
Lars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Calcified Tissue International
|
August 4, 2022
Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study
Maria Luisa Brandi, Suzanne Jan de Beur, Karine Briot, et al.
Page
of 33